⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) Investors - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
MLTX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In MLTX To Contact Him Directly To Discuss Their Options
prnewswire.com
MLTX
MLTX CLASS ACTION NOTICE: Berger Montague Encourages MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action
prnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics(MLTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
prnewswire.com
MLTX
Pomerantz LLP Advises of Securities Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Shareholders that lost money on MoonLake Immunotherapeutics(MLTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
prnewswire.com
MLTX
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
businesswire.com
MLTX
MLTX INVESTOR ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
prnewswire.com
MLTX